Abeona Therapeutics Inc. (0H7R.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 283.83M |
| Enterprise Value | 230.36M |
| P/E Ratio | 4.48 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 22.54 |
| Price/Book Ratio | 2.25 |
| Enterprise/Revenue | 19.91 |
| Enterprise/EBITDA | 3.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 4.55 |
| Operating Margin | -6.38 |
AD
Management Effectiveness
| Return On Assets | 0.33 |
| Return On Equity | 0.41 |
Income Statement
| Revenue | 5.82M |
| Revenue/Share | 0.26 |
| Gross Profit | -1.17M |
| EBITDA | -85.89M |
| Net Income | 71.18M |
| Diluted EPS | 1.01 |
Balance Sheet
| Total Cash | 168.27M |
| Total Cash/Share | 2.97 |
| Total Debt | 23.17M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 5.89 |
| Book Value Per Share | 2.56 |
Price History
| 52-Week Change | 0.35 |
| 52-Week High | 8.8 |
| 52-Week Low | 2.35 |
| Moving Average 50 Days | 6.1 |
| Moving Average 200 Days | 4.53 |
Statistics
| Average Volume | 1,007 |
| Shares Outstanding | 47.94M |
| % Held by Institutions | 74.66 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | July 05, 2022 |
AD
